F-Prime Capital Partners

F-Prime Capital Partners

F-Prime Capital Partners

Date Founded



1 Main Street,13th Floor,Cambridge, MA 02142

Type of Company



Private Equity & Venture Capital
Investment Services & Portfolio Management

Company Description

Impresa focuses on early-stage investments in start-up companies across US and International portfolio companies. There fund focuses on companies operating in the fields of biopharmaceutical, medical technology & healthcare IT and services.There funds are larger and more global. In the US and Europe, they are F-Prime Capital investing in healthcare (formerly Fidelity Biosciences) and in technology (formerly part of Devonshire Investors). In other geographies, there sister fund is called Eight Roads (formerly Fidelity Growth Partners), with investment teams in London, Shanghai, Beijing, Hong Kong, Tokyo, and Mumbai with over $2 trillion in assets under management.

Contact Data
Trying to get in touch with decision makers at F-Prime Capital Partners? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Founding Member

President & Managing Partner

Managing Partner, Tech Fund

Executive Director, Biomedical Research Initiative

Chief Operating Officer/Partner

Executive Partner

Executive Partner


Paths to F-Prime Capital Partners
Potential Connections via
Relationship Science
F-Prime Capital Partners
Recent Transactions
Details Hidden

Electro Optic Systems Holdings Ltd., EOS Defense Systems, Inc. purchase Audacy Corp. from F-Prime Capital Partners, InnoSpring, Inc., Envision Ventures Management LLC, Eight Roads Capital Advisors (UK) Ltd.

Details Hidden

MasterCard, Inc. purchases RiskRecon, Inc. from Accel Partners LLC, General Catalyst LLC, F-Prime Capital Partners, Dell Technologies Capital

Details Hidden

Global Healthcare Exchange LLC, Temasek Capital Pte Ltd., Thoma Bravo LLC purchase Lumere, Inc. from Bessemer Venture Partners, Clayton Associates LLC, F-Prime Capital Partners, Heritage Group LLC, Brainchild Holdings LLC, Silicon Badia Global Partners LLC, Oxeon Investments LLC, Jump Capital LLC, Foley Ventures LLC, Blueprint Health LLC (Venture Capital), Waterline Ventures LLC, Spectrum Health Ventures

Transaction Advisors
Escrow Agent

Advised onZogenix, Inc. purchases Modis Therapeutics, Inc. from F-Prime Capital Partners, Osage Partners LLC, OrbiMed Advisors Private Equity, Aceras BioMedical LLC

Advisors & Consultants

Professional at F-Prime Capital Partners

Details Hidden

SonderMind, Inc. provides healthcare services. It owns and operates an online directory of independent professionals offering mental health, massage, acupuncture, and nutrition services. The company was founded by Sean Boyd and Mark Frank and is headquartered in Denver, CO.

Details Hidden

b-ONE Ortho Corp. engages in the manufacture of orthopedic products. It offers Juveno Femoral Hip System, a tapered wedge femoral stem designed to optimize fit and maximize stability; and b-ONE Primary Acetabular System, a cementless cup technology designed to provide versatility and optimize performance. The company was founded on October 6, 2017 and is headquartered in Cedar Knolls, NJ.

Details Hidden

Quicko Technosoft Labs Pvt Ltd. engages in the provision of internet based software as a service customer engagement solutions. It offers in-app digital guidance; user enablement; 24/7 self-service; alerts and announcements; analytics and feedback; and management and customization. The company was founded by Khadim Batti and Vara Kumar Namburu Maruthi Priya Kanyaka in April 2013 and is headquartered in Bangalore, India.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by F-Prime Capital Partners. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of F-Prime Capital Partners's profile does not indicate a business or promotional relationship of any kind between RelSci and F-Prime Capital Partners.